Fibrogen Inc (KYNB) SEC Filings — 2025
19 SEC filings for Fibrogen Inc (KYNB) in 2025.
Filings
- FibroGen Swings to Profit on China Divestiture, R&D Plummets — 10-Q · Nov 10, 2025
- FibroGen, Inc. Files 8-K Report — 8-K · Nov 6, 2025
- FibroGen Completes Asset Acquisition — 8-K · Sep 5, 2025
- FibroGen, Inc. Files 8-K Reporting Other Events — 8-K · Sep 2, 2025
- FibroGen Inc. Files 8-K Report — 8-K · Aug 18, 2025
- FibroGen Enters Material Definitive Agreement — 8-K · Aug 14, 2025
- FibroGen Narrows Q2 Loss to $10.5M Amid Shifting Revenue Mix — 10-Q · Aug 11, 2025
- FibroGen Files 8-K: Material Agreement and Exhibits — 8-K · Jul 14, 2025
- FibroGen Terminates Material Definitive Agreement — 8-K · Jun 13, 2025
- FibroGen Files 8-K on Security Holder Rights — 8-K · Jun 12, 2025
- FibroGen Reports Material Agreement, Officer Changes — 8-K · Jun 9, 2025
- FibroGen Inc. Files Q1 2025 10-Q — 10-Q · May 12, 2025
- FibroGen Inc. Executive Compensation Details Revealed — DEF 14A · Apr 25, 2025
- FibroGen Files 8-K: Bylaws Amended, Financials Filed — 8-K · Apr 4, 2025
- FibroGen Inc. Files 8-K — 8-K · Mar 31, 2025
- FibroGen Enters Material Definitive Agreement — 8-K · Mar 28, 2025
- FibroGen Inc. Files 2024 Annual Report — 10-K · Mar 17, 2025
- FibroGen Files 8-K: Material Agreement & Exhibits — 8-K · Feb 24, 2025
- FibroGen Reports 8-K with Material Agreements & Officer Changes — 8-K · Feb 20, 2025